SIGA Technologies, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 3.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 218.42M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.